LFG
ORIC icon

Larson Financial Group’s Oric Pharmaceuticals ORIC Stock Holding History

Larson Financial Group’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$877 Buy
81
+45
+125% +$408 ﹤0.01% 3361
2026
Q1 		$456 Buy
+36
New +$409 ﹤0.01% 3328
2025
Q4 		– Sell
-3
Closed -$36 – 3613
2025
Q3 		$36 Buy
+3
New +$32 ﹤0.01% 3371

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Larson Financial Group's ORIC Position: Q2 2026 in Review

Larson Financial Group increased its Oric Pharmaceuticals (ORIC) stake by 125% in Q2 2026, buying an estimated $408 and bringing the position to 81 shares worth $877. The position accounts for ﹤0.01% of the portfolio, ranked #3361.

Larson Financial Group first reported a position in ORIC in Q3 2025 and has held it in 3 quarters since. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Larson Financial Group held 81 shares of Oric Pharmaceuticals worth $877 as of Q2 2026.
  • Larson Financial Group bought 45 Oric Pharmaceuticals shares in Q2 2026, an estimated $408.
  • Oric Pharmaceuticals made up ﹤0.01% of Larson Financial Group's portfolio in Q2 2026, its #3361 holding.
  • Larson Financial Group first reported a position in Oric Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Larson Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.